Marel hf (MAREL.AS) Stock Fundamental Analysis

Europe Euronext Amsterdam AMS:MAREL • IS0000000388

4.55 EUR
+0.12 (+2.71%)
Last: Jan 3, 2025, 07:00 PM
Fundamental Rating

2

Overall MAREL gets a fundamental rating of 2 out of 10. We evaluated MAREL against 112 industry peers in the Machinery industry. MAREL has a bad profitability rating. Also its financial health evaluation is rather negative. MAREL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MAREL was profitable.
  • In the past year MAREL had a positive cash flow from operations.
  • In the past 5 years MAREL has always been profitable.
  • MAREL had a positive operating cash flow in each of the past 5 years.
MAREL.AS Yearly Net Income VS EBIT VS OCF VS FCFMAREL.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.44%, MAREL is doing worse than 63.37% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 1.10%, MAREL is doing worse than 61.39% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.55%, MAREL is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for MAREL is below the industry average of 8.91%.
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROIC 3.55%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%
MAREL.AS Yearly ROA, ROE, ROICMAREL.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.69%, MAREL is doing worse than 62.38% of the companies in the same industry.
  • MAREL's Profit Margin has declined in the last couple of years.
  • MAREL has a Operating Margin (5.21%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of MAREL has declined.
  • MAREL has a Gross Margin (36.06%) which is comparable to the rest of the industry.
  • MAREL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%
MAREL.AS Yearly Profit, Operating, Gross MarginsMAREL.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAREL is destroying value.
  • Compared to 1 year ago, MAREL has about the same amount of shares outstanding.
  • The debt/assets ratio for MAREL has remained at the same level compared to a year ago.
MAREL.AS Yearly Shares OutstandingMAREL.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
MAREL.AS Yearly Total Debt VS Total AssetsMAREL.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.59 indicates that MAREL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of MAREL (2.59) is better than 64.36% of its industry peers.
  • The Debt to FCF ratio of MAREL is 17.03, which is on the high side as it means it would take MAREL, 17.03 years of fcf income to pay off all of its debts.
  • MAREL has a worse Debt to FCF ratio (17.03) than 63.37% of its industry peers.
  • MAREL has a Debt/Equity ratio of 0.84. This is a neutral value indicating MAREL is somewhat dependend on debt financing.
  • The Debt to Equity ratio of MAREL (0.84) is worse than 70.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Altman-Z 2.59
ROIC/WACC0.64
WACC5.55%
MAREL.AS Yearly LT Debt VS Equity VS FCFMAREL.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that MAREL should not have too much problems paying its short term obligations.
  • MAREL has a Current ratio of 1.36. This is in the lower half of the industry: MAREL underperforms 65.35% of its industry peers.
  • A Quick Ratio of 0.77 indicates that MAREL may have some problems paying its short term obligations.
  • MAREL has a Quick ratio of 0.77. This is in the lower half of the industry: MAREL underperforms 69.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.77
MAREL.AS Yearly Current Assets VS Current LiabilitesMAREL.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • The earnings per share for MAREL have decreased strongly by -72.06% in the last year.
  • MAREL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.45% yearly.
  • The Revenue has decreased by -5.67% in the past year.
  • MAREL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.52% yearly.
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.00% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 4.44% on average over the next years.
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue Next Year-0.68%
Revenue Next 2Y2.53%
Revenue Next 3Y3.66%
Revenue Next 5Y4.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MAREL.AS Yearly Revenue VS EstimatesMAREL.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
MAREL.AS Yearly EPS VS EstimatesMAREL.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 227.50, MAREL can be considered very expensive at the moment.
  • MAREL's Price/Earnings ratio is a bit more expensive when compared to the industry. MAREL is more expensive than 66.34% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, MAREL is valued quite expensively.
  • MAREL is valuated quite expensively with a Price/Forward Earnings ratio of 29.78.
  • Based on the Price/Forward Earnings ratio, MAREL is valued a bit more expensive than the industry average as 78.22% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, MAREL is valued at the same level.
Industry RankSector Rank
PE 227.5
Fwd PE 29.78
MAREL.AS Price Earnings VS Forward Price EarningsMAREL.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 75.25% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, MAREL is valued a bit more expensive than the industry average as 67.33% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 67.72
EV/EBITDA 23.03
MAREL.AS Per share dataMAREL.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MAREL does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as MAREL's earnings are expected to grow with 39.00% in the coming years.
PEG (NY)5.03
PEG (5Y)N/A
EPS Next 2Y45.57%
EPS Next 3Y39%

2

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.19%, MAREL is not a good candidate for dividend investing.
  • MAREL's Dividend Yield is comparable with the industry average which is at 1.53.
  • Compared to an average S&P500 Dividend Yield of 1.82, MAREL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

  • The dividend of MAREL decreases each year by -18.19%.
Dividend Growth(5Y)-18.19%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 54.39% of the earnings are spent on dividend by MAREL. This is a bit on the high side, but may be sustainable.
DP54.39%
EPS Next 2Y45.57%
EPS Next 3Y39%
MAREL.AS Yearly Income VS Free CF VS DividendMAREL.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M
MAREL.AS Dividend Payout.MAREL.AS Dividend Payout, showing the Payout Ratio.MAREL.AS Dividend Payout.PayoutRetained Earnings

Marel hf

AMS:MAREL (1/3/2025, 7:00:00 PM)

4.55

+0.12 (+2.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners39.57%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap3.51B
Revenue(TTM)1.66B
Net Income(TTM)11.40M
Analysts84
Price Target0.03 (-99.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.02
Dividend Growth(5Y)-18.19%
DP54.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.24%
PT rev (3m)14.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)12.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE 227.5
Fwd PE 29.78
P/S 2.11
P/FCF 67.72
P/OCF 34.36
P/B 3.39
P/tB N/A
EV/EBITDA 23.03
EPS(TTM)0.02
EY0.44%
EPS(NY)0.15
Fwd EY3.36%
FCF(TTM)0.07
FCFY1.48%
OCF(TTM)0.13
OCFY2.91%
SpS2.16
BVpS1.34
TBVpS-0.44
PEG (NY)5.03
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROCE 4.33%
ROIC 3.55%
ROICexc 3.67%
ROICexgc 12.7%
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
FCFM 3.12%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%
ROICexc(3y)5.48%
ROICexc(5y)7.75%
ROICexgc(3y)24.97%
ROICexgc(5y)39.54%
ROCE(3y)6.38%
ROCE(5y)8.46%
ROICexgc growth 3Y-34.3%
ROICexgc growth 5Y-33.18%
ROICexc growth 3Y-26.23%
ROICexc growth 5Y-21.39%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Debt/EBITDA 4.63
Cap/Depr 49.7%
Cap/Sales 3.03%
Interest Coverage 1.43
Cash Conversion 54.34%
Profit Quality 454.39%
Current Ratio 1.36
Quick Ratio 0.77
Altman-Z 2.59
F-Score5
WACC5.55%
ROIC/WACC0.64
Cap/Depr(3y)100.26%
Cap/Depr(5y)91.26%
Cap/Sales(3y)5.13%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%
Revenue Next Year-0.68%
Revenue Next 2Y2.53%
Revenue Next 3Y3.66%
Revenue Next 5Y4.44%
EBIT growth 1Y-18.13%
EBIT growth 3Y-14.87%
EBIT growth 5Y-11.02%
EBIT Next Year83.77%
EBIT Next 3Y32.66%
EBIT Next 5Y29.2%
FCF growth 1Y333.33%
FCF growth 3Y-25.94%
FCF growth 5Y-13.88%
OCF growth 1Y47.33%
OCF growth 3Y-8.89%
OCF growth 5Y-3.71%

Marel hf / MAREL.AS FAQ

What is the fundamental rating for MAREL stock?

ChartMill assigns a fundamental rating of 2 / 10 to MAREL.AS.


What is the valuation status for MAREL stock?

ChartMill assigns a valuation rating of 1 / 10 to Marel hf (MAREL.AS). This can be considered as Overvalued.


What is the profitability of MAREL stock?

Marel hf (MAREL.AS) has a profitability rating of 3 / 10.


How financially healthy is Marel hf?

The financial health rating of Marel hf (MAREL.AS) is 2 / 10.


How sustainable is the dividend of Marel hf (MAREL.AS) stock?

The dividend rating of Marel hf (MAREL.AS) is 2 / 10 and the dividend payout ratio is 54.39%.